Trial Details

COMPLETED
Basic Information
Clinical ID c1100
Identifier NCT00628433
Trial Title Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: Placebo|DRUG: HE3286
Participant Information
Sponsor Harbor Therapeutics
City Tucson
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1|PHASE2
Time Information
Start Date 2025-02-08
Primary Completion Date 2025-05-09
Completion Date 2025-05-09